BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2886123)

  • 1. Involvement of endopeptidase 24.15 in the inactivation of bradykinin by rat brain slices.
    McDermott JR; Gibson AM; Turner JD
    Biochem Biophys Res Commun; 1987 Jul; 146(1):154-8. PubMed ID: 2886123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidases involved in the catabolism of neurotensin: inhibitor studies using superfused rat hypothalamic slices.
    McDermott JR; Virmani MA; Turner JD; Kidd AM
    Peptides; 1986; 7(2):225-30. PubMed ID: 3526299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic inactivation of bradykinin by rat brain neuronal perikarya.
    DelBel EA; Padovan AP; Padovan GJ; Sellinger OZ; Martins AR
    Cell Mol Neurobiol; 1989 Sep; 9(3):379-400. PubMed ID: 2558804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of neurotensin by rat brain synaptic membranes: involvement of a thermolysin-like metalloendopeptidase (enkephalinase), angiotensin-converting enzyme, and other unidentified peptidases.
    Checler F; Vincent JP; Kitabgi P
    J Neurochem; 1983 Aug; 41(2):375-84. PubMed ID: 6308159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endopeptidases 24.16 and 24.15 are responsible for the degradation of somatostatin, neurotensin, and other neuropeptides by cultivated rat cortical astrocytes.
    Mentlein R; Dahms P
    J Neurochem; 1994 Jan; 62(1):27-36. PubMed ID: 7903352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptosomal membrane-bound form of endopeptidase-24.15 generates Leu-enkephalin from dynorphin1-8, alpha- and beta-neoendorphin, and Met-enkephalin from Met-enkephalin-Arg6-Gly7-Leu8.
    Acker GR; Molineaux C; Orlowski M
    J Neurochem; 1987 Jan; 48(1):284-92. PubMed ID: 2878974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and properties of a neurotensin-degrading endopeptidase from pig brain.
    Millican PE; Kenny AJ; Turner AJ
    Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):583-91. PubMed ID: 1905921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of neurotensin metabolism by regional rat brain slices.
    Davis TP; Gillespie TJ; Konings PN
    J Neurochem; 1992 Feb; 58(2):608-17. PubMed ID: 1729405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain endo-oligopeptidase A, a putative enkephalin converting enzyme.
    Camargo AC; Oliveira EB; Toffoletto O; Metters KM; Rossier J
    J Neurochem; 1987 Apr; 48(4):1258-63. PubMed ID: 2880931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of angiotensin converting enzyme in the vascular effects of an endopeptidase 24.15 inhibitor.
    Telford SE; Smith AI; Lew RA; Perich RB; Madden AC; Evans RG
    Br J Pharmacol; 1995 Mar; 114(6):1185-92. PubMed ID: 7620708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of neurotensin by rabbit brain endo-oligopeptidase A and endo-oligopeptidase B (proline-endopeptidase).
    Camargo AC; Caldo H; Emson PC
    Biochem Biophys Res Commun; 1983 Nov; 116(3):1151-9. PubMed ID: 6316969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of neurotensin by rat brain synaptic membranes. Cleavage at the Pro10-Tyr11 bond by endopeptidase 24.11 (enkephalinase) and a peptidase different from proline-endopeptidase.
    Checler F; Emson PC; Vincent JP; Kitabgi P
    J Neurochem; 1984 Nov; 43(5):1295-301. PubMed ID: 6387047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of endopeptidase-24.15 decreases blood pressure in normotensive rats.
    Genden EM; Molineaux CJ
    Hypertension; 1991 Sep; 18(3):360-5. PubMed ID: 1889849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of thiorphan, bestatin and a novel metallopeptidase inhibitor JMV 390-1 on the recovery of neurotensin and neuromedin N released from mouse hypothalamus.
    Kitabgi P; Dubuc I; Nouel D; Costentin J; Cuber JC; Fulcrand H; Doulut S; Rodriguez M; Martinez J
    Neurosci Lett; 1992 Aug; 142(2):200-4. PubMed ID: 1454216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inhibitor of endopeptidase-24.15 blocks the degradation of intraventricularly administered dynorphins.
    Molineaux CJ; Ayala JM
    J Neurochem; 1990 Aug; 55(2):611-8. PubMed ID: 1973455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of human endopeptidase 3.4.24.16. Comparison with the porcine counterpart indicates a unique cleavage site on neurotensin.
    Vincent B; Vincent JP; Checler F
    Brain Res; 1996 Feb; 709(1):51-8. PubMed ID: 8869556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of bradykinin and its metabolites by rat brain synaptic membranes.
    Orawski AT; Simmons WH
    Peptides; 1989; 10(5):1063-73. PubMed ID: 2608554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growth.
    Paschoalin T; Carmona AK; Rodrigues EG; Oliveira V; Monteiro HP; Juliano MA; Juliano L; Travassos LR
    Mol Cancer; 2007 Jul; 6():44. PubMed ID: 17620116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific binding and proteolytic inactivation of bradykinin by membrane vesicles from pig intestinal smooth muscle.
    Schäfer G; Nau R; Cole T; Conlon M
    Biochem Pharmacol; 1986 Nov; 35(21):3719-25. PubMed ID: 3022739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catabolism of substance P and neurotensin in the rat stomach wall is susceptible to inhibitors of angiotensin converting enzyme.
    Orloff MS; Turner AJ; Bunnett NW
    Regul Pept; 1986 Mar; 14(1):21-31. PubMed ID: 2424051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.